Recent FDA review process of inconclusive clinical studies creates a potentially unhealthy decision-making environment for patients needing gadolinium-enhanced MRIs.
Orest Boyko, MD, PhD
Advertisement
Articles by Orest Boyko, MD, PhD
Advertisement
Latest Updated Articles
U.S. Patients Left Fending For Themselves with Gadolinium Safety RisksDecember 11th 2017
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears AI Software for Automated Measurements on Cardiac MRI
2
CT Radiation Dosing: Where Things Stand, Part 1
3
PET Radiotracer Gets FDA Breakthrough Therapy Designation for Tumor Hypoxia Detection in HPV-Positive Oropharyngeal Carcinoma
4
Is FAPI PET More Advantageous Than CECT for Detecting Peritoneal Carcinomatosis in Patients with Ovarian Cancer?
5